Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
JNJ-42847922, 20 mg
DRUG
2 trials
Sponsors
Janssen Pharmaceutical K.K.
, Janssen Research & Development, LLC
Conditions
Healthy
Insomnia Disorders
Phase 1
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-42847922 in Healthy Japanese Male Participants
Completed
NCT02555124
Janssen Pharmaceutical K.K.
Healthy
Start: 2015-09-12
End: 2015-10-31
Updated: 2017-03-10
Phase 2
A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder
Completed
NCT03375203
Janssen Research & Development, LLC
Insomnia Disorders
Start: 2017-11-23
End: 2019-04-03
Updated: 2025-04-29
Related Papers
Efficacy and Safety of Seltorexant in Insomnia Disorder
JAMA Psychiatry
2025-08-13
4 citations
0504 Efficacy and Safety of Seltorexant in Insomnia Disorder
SLEEP
2020-04-01
4 citations